Sonia Brun

Dr. Sonia Brun

Department of Biomedicine, Universitat de Barcelona, Barcelona, Catalonia, Spain
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1999 in Diabetes
Verified
Journal Article
Closed access
PDF file
SBSonia Brun
Sonia Brun
MCM C Carmona
M C Carmona
TMT Mampel
T Mampel
OVO Viñas
O Viñas
Marta GiraltMarta Giralt
Marta Giralt
FVFrancesc Villarroya
Francesc Villarroya
The recently identified uncoupling protein-3 (UCP-3) gene, predicted to encode a new member of the family of uncoupling proteins, is preferentially expressed in skeletal muscle and has been related to phenotypes of obesity and type 2 diabetes. We have established that during mouse ontogeny, the expression of the UCP-3 gene is switched on in skeletal muscle just after birth. The induction of UCP-3 gene expression is dependent on the initiation of suckling and particularly on lipid intake. Treatment of newborn mice with activators of peroxisome proliferator-activated receptors (PPARs), such as clofibrate, bezafibrate, or (4-chloro-6-(2,3-xylidine)-pirimidinylthio)acetic acid (WY 14,643), mimics the action of food intake on UCP-3 gene expression. The specific ligand of PPAR-alpha WY 14,643 induces UCP-3 gene expression in a time- and dose-dependent manner, whereas the thiazolidinedione BRL 49653, specific for PPAR-gamma, has no effect. These treatments act without altering circulating free fatty acids. During development, skeletal muscle expresses constitutive levels of PPAR-delta mRNA, whereas expression of the PPAR-gamma gene is undetectable. PPAR-alpha gene expression is developmentally regulated in muscle as it is first expressed at birth, just before UCP-3 gene induction occurs. The induction of UCP-3 gene expression by WY 14,643 is impaired in skeletal muscle of premature neonates, which do not express PPAR-alpha. It is proposed that the UCP-3 gene is predominantly regulated in neonatal muscle by PPAR-alpha activation.

17 June 1999 in FEBS Letters
Verified
Journal Article
Open access
PDF file
SBSonia Brun
Sonia Brun
MCM.C Carmona
M.C Carmona
TMT Mampel
T Mampel
OVO Viñas
O Viñas
Marta GiraltMarta Giralt
Marta Giralt
FVFrancesc Villarroya
Francesc Villarroya
Uncoupling protein‐3 gene expression in skeletal muscle is up‐regulated during postnatal development of mice. A high‐carbohydrate diet at weaning induces a decrease in uncoupling protein‐3 mRNA levels that does not occur when mice were weaned onto a high‐fat diet. Uncoupling protein‐3 mRNA levels do not increase in response to fasting in young pups. Only after day 15 of life, when fasting increases serum non‐esterified fatty acids, uncoupling protein‐3 mRNA is up‐regulated by starvation. Over‐nutrition or under‐nutrition during lactation increases or decreases, respectively, uncoupling protein‐3 mRNA expression in skeletal muscle. Regulation of uncoupling protein‐3 gene expression in skeletal muscle during development is mediated by ontogenic and nutritional factors determining changes in circulating non‐esterified fatty acids.

1 February 1998 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MCM.CArmen Carmona
M.CArmen Carmona
AVAngel Valmaseda
Angel Valmaseda
SBSonia Brun
Sonia Brun
OVOctavi Viñas
Octavi Viñas
TMTeresa Mampel
Teresa Mampel
FVFrancesc Villarroya
Francesc Villarroya

12 November 2007 in Proteomics
Verified
Journal Article
Closed access
PDF file
ESElielson Souza‐Rodrígues
Elielson Souza‐Rodrígues
JEJosep M. Estanyol
Josep M. Estanyol
EFErica Friedrich‐Heineken
Erica Friedrich‐Heineken
EOEva Olmedo
Eva Olmedo
JVJorge Vera
Jorge Vera
MJMontserrat Jaumot
Montserrat Jaumot

1 August 2005 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
ARAina Rodríguez-Vilarrupla
Aina Rodríguez-Vilarrupla
MJMontserrat Jaumot
Montserrat Jaumot
NANeus Abella
Neus Abella
NCNúria Canela
Núria Canela
SBSonia Brun
Sonia Brun
NANeus Agell
Neus Agell
Intracellular localization plays an important role in the functional regulation of the cell cycle inhibitor p21. We have previously shown that calmodulin binds to p21 and that calmodulin is essential for the nuclear accumulation of p21. Here, we analyze the mechanism of this regulation. We show that calmodulin inhibits in vitro phosphorylation of p21 by protein kinase C (PKC) and that this inhibition is dependent upon calmodulin binding to p21. Two-dimensional electrophoresis analysis of cells expressing the p21 wild type or p21S153A, a nonphosphorylatable mutant of p21 at position 153, indicates that Ser153 of p21 is a phosphorylable residue in vivo. Furthermore, Western blot analysis using phospho-Ser153-specific antibodies indicates that Ser153 phosphorylation in vivo is induced when PKC is activated and calmodulin is inhibited. The mutation of Ser153 to aspartate, a pseudophosphorylated residue, inhibits the nuclear accumulation of p21. Finally, whereas wild-type p21 translocates to the cytoplasm after PKC activation in the presence of calmodulin inhibitors, p21 carrying a nonphosphorylatable residue at position 153 remains in the nucleus. We propose that calmodulin binding to p21 prevents its phosphorylation by PKC at Ser153 and consequently allows its nuclear localization. When phosphorylated at Ser153, p21 is located at the cytoplasm and disrupts stress fibers.

19 March 2010 in Traffic
Verified
Journal Article
Closed access
PDF file
NANeus Abella
Neus Abella
SBSonia Brun
Sonia Brun
MCMaria Calvo
Maria Calvo
OTOlga Tapia
Olga Tapia
JWJason D. Weber
Jason D. Weber
NANeus Agell
Neus Agell